Gradalis, Inc. logo

Gradalis, Inc. Employee Directory

Biotechnology ResearchTexas, United States11-50 Employees

Gradalis, Inc. is a late-stage biotechnology company based in Carrollton, Texas, focused on immunotherapies for cancer. Its lead program, Vigil, is a cellular immunotherapy that uses a patient’s tumor antigens to guide the immune system in recognizing and attacking cancer cells, and has shown positive survival signals in prior studies of solid tumors. The company’s proprietary bi-shRNA platform underpins Vigil and aims to modulate immune pathways to enhance anti-tumor responses across multiple cancer types.
Gradalis is advancing a Phase 3 registration study in ovarian cancer, signaling progression toward potential approval for a key indication. In January 2026, the company appointed Steven D. Weinstein as chief executive officer, reflecting leadership change as it pursues late-stage development.

Find Gradalis, Inc. employees' phone numbers or email addresses

Gradalis, Inc. Global Highlights

Location
Employees

North America
54

Minus sign iconPlus sign icon
  • United States Of America
    54

Gradalis, Inc.'s Leadership

  • Stylized image of a person
    E. B.
    Chief Operating Officer
    Phone icon
  • Stylized image of a person
    A. W.
    Vice President Medical And Scientific Affairs
    Phone icon
  • Stylized image of a person
    R. L.
    Managing Partner
    Phone icon
  • Stylized image of a person
    R. S.
    Assistant Medical Director
    Phone icon
  • Stylized image of a person
    L. M.
    Medical Director
    Phone icon
  • Stylized image of a person
    G. M.
    Personnel
    Phone icon
  • Stylized image of a person
    M. B.
    Internship
    Phone icon

Gradalis, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Quality Assurance
  • Accounting
  • Administrative
  • Biotechnology
  • Business
  • Other
  • Entrepreneurship

Contact profiles from Gradalis, Inc.

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    E. B.
    Chief Operating Officer
    Phone icon
    Jun 27, 2026
  • Stylized image of a person
    R. L.
    Managing Partner
    Phone icon
    Oct 23, 2024
  • Stylized image of a person
    A. W.
    Vice President Medical And Scientific Affairs
    Phone icon
    Oct 21, 2024
  • Stylized image of a person
    R. S.
    Assistant Medical Director
    Phone icon
    Oct 18, 2024
  • Stylized image of a person
    L. M.
    Medical Director
    Phone icon
    Jan 15, 2026
  • Stylized image of a person
    G. M.
    Personnel
    Phone icon
    Oct 22, 2024
  • Stylized image of a person
    M. B.
    Internship
    Phone icon
    Apr 23, 2025

Frequently Asked Questions

What is Gradalis, Inc. known for?

Minus sign iconPlus sign icon
Gradalis, Inc. was founded in 2003 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at . Explore Gradalis, Inc.'s company overview page for more information.

What is Gradalis, Inc.'s most common email format?

Minus sign iconPlus sign icon
Gradalis, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Gradalis, Inc. email formats with LeadIQ.

How many employees does Gradalis, Inc. have currently?

Minus sign iconPlus sign icon
Gradalis, Inc. has approximately 27 employees as of July 2026. These team members are located across 1 continents, including North America.

Who are Gradalis, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Gradalis, Inc.'s key employees include:

  • Chief Operating Officer: E. B.
  • Vice President Medical And Scientific Affairs: A. W.
  • Managing Partner: R. L.
  • Assistant Medical Director: R. S.
  • Medical Director: L. M.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.